Rectal Cancer Clinical Trials in Montvale, New Jersey

4 studies are recruiting for rectal cancer in Montvale, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

    This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limited surgery? If radiation therapy is not given, is quality of…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Bergen, Montvale, New Jersey
    Locations
    113 in total
    Run by
    Canadian Cancer Trials Group

    See if you can join NCT06205485 on ClinicalTrials.gov

  2. A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

    The purpose of the study is to learn more about how the body responds to standard treatment (chemoradiation and chemotherapy). The study will use the results of testing down on participants' blook, tissue, and scans to learn more about how people with rectal cancer respond to chemoradiation and che…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey
    Locations
    6 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT06637462 on ClinicalTrials.gov

  3. A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

    The study researchers believe that a combination of the drugs trastuzumab and tucatinib, given with standard chemotherapy (capecitabine and oxaliplatin/FOLFOX), may help participants with rectal cancer.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05672524 on ClinicalTrials.gov

  4. A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

    The researchers are doing this study to find out whether the combination of botensilimab and balstilimab (BOT/BAL), followed by balstilimab alone, is an effective treatment for people with microsatellite stable (MSS) colorectal cancer or colorectal liver metastases (CRLM) who have measurable residu…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07227636 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.